Skip to main content
. Author manuscript; available in PMC: 2021 Apr 24.
Published in final edited form as: Circ Res. 2020 Apr 23;126(9):1209–1227. doi: 10.1161/CIRCRESAHA.119.315939

Table 1.

Macrophage immunometabolism and atherosclerosis

Metabolite/
regulating step
Cellular
source
Possible
stimuli in
lesion
Effect on macrophages Effect on atherosclerosis
Intracellular
Glucose/SLC2A1 Apoptotic cell, TLR4 ligands hypoxia Altered inflammation and increased efferocytosis21, 50, 124 Prevention of necrotic cores* (mouse)50, 124
Lactate TLR4 ligands, hypoxia, oxLDL Resolution of inflammation16 Unknown
Non-oxPPP/SHPK IL-4 Suppression of inflammatory activation17 Unknown
Succinate TLR4 ligands IL-1β production Unknown
Citrate TLR4 ligands TNF-α translation37 Unknown
α-ketoglutarate TLR4 ligands LPS tolerance39 Unknown
Itaconate/ACOD1 TLR4 ligands Resolution of inflammation and LPS tolerance41 Unknown
Oxaloacetate/citrate oxPAPC IL-1β production64 Promotes atherosclerosis^ (mouse)64
Arginine/Arg1 IL-4 Promotes foam cell formation143 No effect on atherosclerosis§ (mouse)143
Arginine/iNOS TLR4 ligands Suppresses IL-12 production144 Promotes lesion area§ (mouse)145
Serine TLR4 ligands IL-1β production67, 68 Unknown
Acyl-CoA/ACSL1 TLR4 ligands, oxLDL Promotes inflammatory activation86, 89 Promotes lesion initiation* (diabetic mouse)86
Fatty acids/FAS oxysterols Promotes lipid loading146 Promotes atherosclerosis* (mouse)146
Fatty acids/FABP4 oxLDL Promotes inflammatory activation and CE accumulation84 Promotes lesion area§ (mouse)84
Mitochondrial ROS oxLDL Promotes CCL2, IL-1β, and IL-6 production55, 78 Promotes lesion initiation* (mouse)78
Associated with coronary artery disease (humans)55
Intracellular
Lactate/SLC16A1 MΦ cargo Apoptotic cell Resolution of inflammation50 Unknown
Lesional cells Inflammation, hypoxia
Succinate/ SUCNR1 Lesional cells TLR4 ligands IL-1β28 Unknown
Arginine/putrescine MΦ cargo Apoptotic cell Continual efferocytosis125 Promotes lesion regression (mouse)125

CE, cholesteryl ester; HK1, hexokinase 1; MΦ, macrophage; non-oxPPP, non-oxidative phase of pentose phosphate pathway; SLC2A1, GLUT1

*

Myeloid cell targeted deletion or overexpression

§

Hematopoietic deletion (bone marrow transplant)

^

Indirect evidence